go to main content
Research Research groups Molecular therapy for hereditary retinal disorders

About

We aim to develop therapeutic interventions for patients with rare inherited retinal disease. Based on the causative genetic defect, and using various model systems, we design and develop strategies to correct DNA and RNA defects, with the ultimate aim to prevent patients from getting blind.

Research group leader

dr. Rob Collin

contact form

Publications

See some of our most important scientific articles.

read more
Listen

Publications

See the publication list of the research group leader on Web of Science.


Profile page

See the group leader's profile.

see page

Research programs

Programs that are connected to this research group.